Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations. Camillo Porta , Aristotelis Bamias , Roubini Zakopoulou , Zin W Myint , Nicolò Cavasin , Roberto Iacovelli , Martin Pichler , Jindrich Kopecky , Jakub Kucharz , Mimma Rizzo , Luca Galli , Thomas Büttner , Ugo DE Giorgi , Ravindran Kanesvaran , Ondřej Fiala , Enrique Grande , Paolo A Zucali , Ray M Kopp , Giuseppe Fornarini , Maria T Bourlon , Sarah Scagliarini , Javier Molina-Cerrillo , Gaetano Aurilio , Marc R Matrana , Renate Pichler , Carlo Cattrini , Tomáš Büchler , Francesco Massari , Veronica Mollica , Emmanuel Seront , Fabio Calabrò , Alvaro Pinto , Rossana Berardi , Anca Zgura , Giulia Mammone , Jawaher Ansari , Francesco Atzori , Rita Chiari , Orazio Caffo , Giuseppe Procopio , Kaisa Sunela , Maria Bassanelli , Cinzia Ortega , Francesco Grillone , Johannes Landmesser , Sara Merler , Carlo Messina , Zsófia Küronya , Alessandra Mosca , Dipen Bhuva , Daniele Santini , Nuno Vau , Franco Morelli , Lorena Incorvaia , Sara E Rebuzzi , Giandomenico Roviello , Andrey Soares , Ignacio O Zabalza , Alessandro Rizzo , Renato Bisonni , Francesco Pierantoni , Giulia Sorgentoni , Fernando S Monteiro , Nicola Battelli , Sebastiano Buti , Matteo Santoni Minerva urology and nephrology（2023）
摘要
No significant differences in terms of patients' outcome seem to clearly emerge, even if the rate CN and the choice of the type of first-line immune-based combination varies across the different Cancer Centers participating in the ARON-1 project.
更多 查看译文
关键词
renal cell carcinoma, metastatic de novo, geographical differences, immune-combinations
AI 理解论文
溯源树
样例
